Early research (Phase 1)Study completedNCT04043104
What this trial is testing
Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia
Who this might be right for
Radiation-Induced Parotid Gland HypofunctionXerostomia Due to RadiotherapyHead and Neck Cancer
MeiraGTx UK II Ltd 24